Chaos and reliability in balanced spiking networks with temporal drive

le Lajoie, Guillaume, Lin, Kevin K., Shea-Brown, Eric
Foilsithe 2013

Including probe-level uncertainty in model-based gene expression clustering

le Liu, Xuejun, Lin, Kevin K, Andersen, Bogi, Rattray, Magnus
Foilsithe 2007

Phase-Amplitude Descriptions of Neural Oscillator Models

le Wedgwood, Kyle CA, Lin, Kevin K, Thul, Ruediger, Coombes, Stephen
Foilsithe 2013

The influence of multiple firing events on the formation and stability of activity patterns in continuous attractor networks

le Lyttle, David, Weitzenfeld, Alfredo, Fellous, Jean-Marc, Lin, Kevin K
Foilsithe 2013

Spatial scale and place field stability in a grid-to-place cell model of the dorsoventral axis of the hippocampus

le Lyttle, David, Gereke, Brian, Lin, Kevin K., Fellous, Jean-Marc
Foilsithe 2013

The epidermal differentiation-associated Grainyhead gene Get1/Grhl3 also regulates urothelial differentiation

le Yu, Zhengquan, Mannik, Jaana, Soto, Amelia, Lin, Kevin K, Andersen, Bogi
Foilsithe 2009

Estimating replicate time shifts using Gaussian process regression

le Liu, Qiang, Lin, Kevin K., Andersen, Bogi, Smyth, Padhraic, Ihler, Alexander
Foilsithe 2010

Bayesian detection of non-sinusoidal periodic patterns in circadian expression data

le Chudova, Darya, Ihler, Alexander, Lin, Kevin K., Andersen, Bogi, Smyth, Padhraic
Foilsithe 2009

Encoding in Balanced Networks: Revisiting Spike Patterns and Chaos in Stimulus-Driven Systems

le Lajoie, Guillaume, Lin, Kevin K., Thivierge, Jean-Philippe, Shea-Brown, Eric
Foilsithe in PLoS Comput Biol (2016)

Identification of hair cycle-associated genes from time-course gene expression profile data by using replicate variance

le Lin, Kevin K., Chudova, Darya, Hatfield, G. Wesley, Smyth, Padhraic, Andersen, Bogi
Foilsithe 2004

Circadian Clock Genes Contribute to the Regulation of Hair Follicle Cycling

le Lin, Kevin K., Kumar, Vivek, Geyfman, Mikhail, Chudova, Darya, Ihler, Alexander T., Smyth, Padhraic, Paus, Ralf, Takahashi, Joseph S., Andersen, Bogi
Foilsithe 2009

Network analysis of skin tumor progression identifies a rewired genetic architecture affecting inflammation and tumor susceptibility

le Quigley, David A, To, Minh D, Kim, Il Jin, Lin, Kevin K, Albertson, Donna G, Sjolund, Jonas, Pérez-Losada, Jesús, Balmain, Allan
Foilsithe 2011

Co-factors of LIM domains (Clims/Ldb/Nli) regulate corneal homeostasis and maintenance of hair follicle stem cells

le Xu, Xiaoman, Mannik, Jaana, Kudryavtseva, Elena, Lin, Kevin K., Flanagan, Lisa A., Spencer, Joel, Soto, Amelia, Wang, Ning, Lu, Zhongxian, Yu, Zhengquan, Monuki, Edwin S., Andersen, Bogi
Foilsithe 2007

A Quantitative Chemotherapy Genetic Interaction Map Reveals Factors Associated with PARP Inhibitor Resistance

le Hu, Hsien-Ming, Zhao, Xin, Kaushik, Swati, Robillard, Lilliane, Barthelet, Antoine, Lin, Kevin K., Shah, Khyati N., Simmons, Andy D., Raponi, Mitch, Harding, Thomas C., Bandyopadhyay, Sourav
Foilsithe in Cell Rep (2018)

Rucaparib Monotherapy in Patients With Pancreatic Cancer and a Known Deleterious BRCA Mutation

le Shroff, Rachna T., Hendifar, Andrew, McWilliams, Robert R., Geva, Ravit, Epelbaum, Ron, Rolfe, Lindsey, Goble, Sandra, Lin, Kevin K., Biankin, Andrew V., Giordano, Heidi, Vonderheide, Robert H., Domchek, Susan M.
Foilsithe in JCO Precis Oncol (2018)

Methylation of all BRCA1 copies predicts response to the PARP inhibitor rucaparib in ovarian carcinoma

le Kondrashova, Olga, Topp, Monique, Nesic, Ksenija, Lieschke, Elizabeth, Ho, Gwo-Yaw, Harrell, Maria I., Zapparoli, Giada V., Hadley, Alison, Holian, Robert, Boehm, Emma, Heong, Valerie, Sanij, Elaine, Pearson, Richard B., Krais, John J., Johnson, Neil, McNally, Orla, Ananda, Sumitra, Alsop, Kathryn, Hutt, Karla J., Kaufmann, Scott H., Lin, Kevin K., Harding, Thomas C., Traficante, Nadia, deFazio, Anna, McNeish, Iain A., Bowtell, David D., Swisher, Elizabeth M., Dobrovic, Alexander, Wakefield, Matthew J., Scott, Clare L.
Foilsithe in Nat Commun (2018)

Rucaparib maintenance treatment for recurrent ovarian carcinoma after response to platinum therapy (ARIEL3): a randomised, double-blind, placebo-controlled, phase 3 trial

le Coleman, Robert L, Oza, Amit M, Lorusso, Domenica, Aghajanian, Carol, Oaknin, Ana, Dean, Andrew, Colombo, Nicoletta, Weberpals, Johanne I, Clamp, Andrew, Scambia, Giovanni, Leary, Alexandra, Holloway, Robert W, Gancedo, Margarita Amenedo, Fong, Peter C, Goh, Jeffrey C, O’Malley, David M, Armstrong, Deborah K, Garcia-Donas, Jesus, Swisher, Elizabeth M, Floquet, Anne, Konecny, Gottfried E, McNeish, Iain A, Scott, Clare L, Cameron, Terri, Maloney, Lara, Isaacson, Jeff, Goble, Sandra, Grace, Caroline, Harding, Thomas C, Raponi, Mitch, Sun, James, Lin, Kevin K, Giordano, Heidi, Ledermann, Jonathan A
Foilsithe in Lancet (2017)

Secondary Somatic Mutations Restoring RAD51C and RAD51D Associated with Acquired Resistance to the PARP Inhibitor Rucaparib in High-Grade Ovarian Carcinoma

le Kondrashova, Olga, Nguyen, Minh, Shield-Artin, Kristy, Tinker, Anna V., Teng, Nelson N.H., Harrell, Maria I., Kuiper, Michael J., Ho, Gwo-Yaw, Barker, Holly, Jasin, Maria, Prakash, Rohit, Kass, Elizabeth M., Sullivan, Meghan R., Brunette, Gregory J., Bernstein, Kara A., Coleman, Robert L., Floquet, Anne, Friedlander, Michael, Kichenadasse, Ganessan, O'Malley, David M., Oza, Amit, Sun, James, Robillard, Liliane, Maloney, Lara, Giordano, Heidi, Wakefield, Matthew J., Kaufmann, Scott H., Simmons, Andrew D., Harding, Thomas C., Raponi, Mitch, McNeish, Iain A., Swisher, Elizabeth M., Lin, Kevin K., Scott, Clare L.
Foilsithe in Cancer Discov (2017)

Molecular and clinical determinants of response and resistance to rucaparib for recurrent ovarian cancer treatment in ARIEL2 (Parts 1 and 2)

le Swisher, Elizabeth M., Kwan, Tanya T., Oza, Amit M., Tinker, Anna V., Ray-Coquard, Isabelle, Oaknin, Ana, Coleman, Robert L., Aghajanian, Carol, Konecny, Gottfried E., O’Malley, David M., Leary, Alexandra, Provencher, Diane, Welch, Stephen, Chen, Lee-may, Wahner Hendrickson, Andrea E., Ma, Ling, Ghatage, Prafull, Kristeleit, Rebecca S., Dorigo, Oliver, Musafer, Ashan, Kaufmann, Scott H., Elvin, Julia A., Lin, Douglas I., Chambers, Setsuko K., Dominy, Erin, Vo, Lan-Thanh, Goble, Sandra, Maloney, Lara, Giordano, Heidi, Harding, Thomas, Dobrovic, Alexander, Scott, Clare L., Lin, Kevin K., McNeish, Iain A.
Foilsithe in Nat Commun (2021)

Characterization of a RAD51C-silenced high-grade serous ovarian cancer model during development of PARP inhibitor resistance

le Hurley, Rachel M, McGehee, Cordelia D, Nesic, Ksenija, Correia, Cristina, Weiskittel, Taylor M, Kelly, Rebecca L, Venkatachalam, Annapoorna, Hou, Xiaonan, Pathoulas, Nicholas M, Meng, X Wei, Kondrashova, Olga, Radke, Marc R, Schneider, Paula A, Flatten, Karen S, Peterson, Kevin L, Becker, Marc A, Wong, Ee Ming, Southey, Melissa S, Dobrovic, Alexander, Lin, Kevin K, Harding, Thomas C, McNeish, Iain, Ross, Christian A, Wagner, Jill M, Wakefield, Matthew J, Scott, Clare L, Haluska, Paul, Wahner Hendrickson, Andrea E, Karnitz, Larry M, Swisher, Elizabeth M, Li, Hu, Weroha, S John, Kaufmann, Scott H
Foilsithe in NAR Cancer (2021)